Literature DB >> 17389745

Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery.

Conor C Murphy1, Steven Nicholson, Say Aun Quah, Mark Batterbury, Timothy Neal, Stephen B Kaye.   

Abstract

AIM: To determine the elimination kinetics of intracameral vancomycin administered as a bolus injection at the end of phacoemulsification cataract surgery.
METHODS: Vancomycin 1 mg/0.1 ml saline solution was administered to 19 patients by intracameral bolus injection at the end of routine cataract surgery. The aqueous concentration of vancomycin was determined in nine patients 1 minute after administration and in 10 patients 18-24 hours postoperatively. Aqueous samples were obtained by inserting a Rycroft cannula into the anterior chamber via the side port incision. Fluorescence polarisation immunoassay was used to calculate the aqueous vancomycin concentration.
RESULTS: The median (interquartile range) vancomycin concentration was 5458 (4756-6389) mg/l at 1 minute and 40.6 (25.9-47.1) mg/l 18 to 24 hours (median 19 hours) postoperatively. The vancomycin concentration exceeded the minimum inhibitory concentration (MIC) of endophthalmitis-causing gram-positive bacteria by a factor of 4 for up to 26 hours postoperatively. No adverse event or reaction was noted.
CONCLUSION: Following bolus intracameral injection at the end of cataract surgery the concentration of vancomycin in the anterior chamber vastly exceeds its MIC for at least 24 hours but is predicted to fall below the MIC after 33 hours.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389745      PMCID: PMC2001025          DOI: 10.1136/bjo.2006.112060

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment.

Authors:  John F Wilson; Alan C Davis; Caroline M Tobin
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

2.  Filters and antibiotics in irrigating solution for cataract surgery.

Authors:  J P Gills
Journal:  J Cataract Refract Surg       Date:  1991-05       Impact factor: 3.351

3.  Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.

Authors:  P M Small; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  A compartmental model for the ocular pharmacokinetics of cyclosporine in rabbits.

Authors:  C Oh; B A Saville; Y L Cheng; D S Rootman
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

5.  Anterior chamber aspirate cultures after uncomplicated cataract surgery.

Authors:  J B Dickey; K D Thompson; W M Jay
Journal:  Am J Ophthalmol       Date:  1991-09-15       Impact factor: 5.258

6.  Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits.

Authors:  M Mayers; D Rush; A Madu; M Motyl; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia.

Authors:  M J Rybak; E M Bailey; K C Lamp; G W Kaatz
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

8.  Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin.

Authors:  S C Pflugfelder; E Hernández; S J Fliesler; J Alvarez; M E Pflugfelder; R K Forster
Journal:  Arch Ophthalmol       Date:  1987-06

9.  Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model.

Authors:  Peter E Libre; Phyllis Della-Latta; Nai Xun Chin
Journal:  J Cataract Refract Surg       Date:  2003-09       Impact factor: 3.351

10.  Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1995-12
View more
  10 in total

1.  Surgical Antimicrobial Prophylaxis in Patients of Neonatal and Pediatric Age Subjected to Eye Surgery: A RAND/UCLA Appropriateness Method Consensus Study.

Authors:  Sonia Bianchini; Chiara Morini; Laura Nicoletti; Sara Monaco; Erika Rigotti; Caterina Caminiti; Giorgio Conti; Maia De Luca; Daniele Donà; Giuseppe Maglietta; Laura Lancella; Andrea Lo Vecchio; Giorgio Marchini; Carlo Pietrasanta; Nicola Principi; Alessandro Simonini; Elisabetta Venturini; Rosa Longo; Elena Gusson; Domenico Boccuzzi; Luca Vigo; Fabio Mosca; Annamaria Staiano; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-04-22

2.  Are cefuroxime and vancomycin really safe on the corneal endothelial cells?

Authors:  Tök Y Ozlem; Demir M Necati; Yilmaz M Fatma; Yilmaz Gülsen; Nurözler B Ayşe; Ornek Firdevs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03       Impact factor: 3.117

3.  Pharmacokinetics of intracameral voriconazole injection.

Authors:  Ying-Cheng Shen; Mei-Yen Wang; Chun-Yuan Wang; Tsun-Chung Tsai; Hin-Yeung Tsai; Hsin-Nung Lee; Li-Chen Wei
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

4.  Comparison of different techniques of cataract surgery in bacterial contamination of the anterior chamber in diabetic and non-diabetic population.

Authors:  M Ashok Kumar; Sheen S Kurien; Stephen Selvaraj; Uma Devi; S Selvasundari
Journal:  Indian J Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 1.848

5.  Controlled Release of Vancomycin From a Thermoresponsive Hydrogel System for the Prophylactic Treatment of Postoperative Acute Endophthalmitis.

Authors:  Emily Dosmar; Wenqiang Liu; Geeya Patel; Alison Rogozinski; William F Mieler; Jennifer J Kang-Mieler
Journal:  Transl Vis Sci Technol       Date:  2019-06-27       Impact factor: 3.283

Review 6.  Postoperative Endophthalmitis After Cataract Surgery: An Update.

Authors:  Saad Althiabi; Abdulaziz J Aljbreen; Asma Alshutily; Faisal A Althwiny
Journal:  Cureus       Date:  2022-02-08

7.  Moxifloxacin releasing intraocular implant based on a cross-linked hyaluronic acid membrane.

Authors:  Dong Ju Kim; Mi-Young Jung; Joo-Hee Park; Ha-Jin Pak; Martha Kim; Roy S Chuck; Choul Yong Park
Journal:  Sci Rep       Date:  2021-12-16       Impact factor: 4.379

8.  Emerging Antibiotic Resistance Patterns Affect Visual Outcome Treating Acute Endophthalmitis.

Authors:  Xia-Ni Wu; Yi-Hsing Chen; Lazha Sharief; Ahmed Al-Janabi; Nura Al Qassimi; Sue Lightman; Oren Tomkins-Netzer
Journal:  Antibiotics (Basel)       Date:  2022-06-23

9.  Postcataract endophthalmitis prophylaxis using irrigation, incision hydration, and eye pressurization with vancomycin.

Authors:  Lee P Schelonka; Margaret A SaBell
Journal:  Clin Ophthalmol       Date:  2015-07-17

10.  Intraoperative Cefuroxime Irrigation Prophylaxis for Acute-Onset Endophthalmitis After Phacoemulsification Surgery.

Authors:  Xiubin Ma; Lixin Xie; Yusen Huang
Journal:  Infect Drug Resist       Date:  2020-05-18       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.